Barry Flannelly

Direktor/Vorstandsmitglied bei PROTARA THERAPEUTICS, INC.

Vermögen: 4 Mio $ am 31.05.2024

66 Jahre

Health Technology

Consumer Services

Aktive Positionen von Barry Flannelly

Unternehmen	Position	Beginn	Ende
INCYTE CORPORATION	Corporate Officer/Principal	01.08.2014	-
PROTARA THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	23.07.2020	-
PROTARA THERAPEUTICS, INC.	Independent Dir/Board Member	23.07.2020	-

Unternehmen	Position	Beginn	Ende
GENOMIC HEALTH, INC.	Direktor/Vorstandsmitglied	16.04.2019	08.11.2019
OSS Healthcare, Inc.	Vorstandsvorsitzender	01.08.2013	01.07.2014
NEKTAR THERAPEUTICS	Corporate Officer/Principal	01.04.2011	01.04.2013
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Corporate Officer/Principal	01.08.2008	01.01.2011
Johns Hopkins Oncology Center	Corporate Officer/Principal	-	-

Massachusetts College of Pharmacy & Health Science	Undergraduate Degree
University of Baltimore	Masters Business Admin
University of Maryland School of Pharmacy	Doctorate Degree

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	4
Director/Board Member	2
Doctorate Degree	1

Sektoral

Health Technology	6
Consumer Services	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
INCYTE CORPORATION	Health Technology
NEKTAR THERAPEUTICS	Health Technology
PROTARA THERAPEUTICS, INC.	Health Technology

Private Unternehmen	4
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA.	Health Technology
Genomic Health, Inc. Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.	Health Technology
OSS Healthcare, Inc.
Johns Hopkins Oncology Center